These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18713514)

  • 1. Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint.
    Toennes SW; Ramaekers JG; Theunissen EL; Moeller MR; Kauert GF
    J Anal Toxicol; 2008 Sep; 32(7):470-7. PubMed ID: 18713514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid.
    Kauert GF; Ramaekers JG; Schneider E; Moeller MR; Toennes SW
    J Anal Toxicol; 2007 Jun; 31(5):288-93. PubMed ID: 17579974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
    Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
    Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic properties of delta9-tetrahydrocannabinol in oral fluid of occasional and chronic users.
    Toennes SW; Ramaekers JG; Theunissen EL; Moeller MR; Kauert GF
    J Anal Toxicol; 2010 May; 34(4):216-21. PubMed ID: 20465868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
    Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users.
    Toennes SW; Schneider K; Kauert GF; Wunder C; Moeller MR; Theunissen EL; Ramaekers JG
    Anal Bioanal Chem; 2011 Apr; 400(1):145-52. PubMed ID: 21116612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum cannabinoid levels 24 to 48 hours after cannabis smoking].
    Skopp G; Richter B; Pötsch L
    Arch Kriminol; 2003; 212(3-4):83-95. PubMed ID: 14639811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid concentrations in spot serum samples 24-48 hours after discontinuation of cannabis smoking.
    Skopp G; Pötsch L
    J Anal Toxicol; 2008 Mar; 32(2):160-4. PubMed ID: 18334100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
    Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
    J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette.
    Marsot A; Audebert C; Attolini L; Lacarelle B; Micallef J; Blin O
    J Pharm Pharm Sci; 2016; 19(3):411-422. PubMed ID: 27806250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Δ9-tetrahydrocannabinol (THC) is present in the body between smoking sessions in occasional non-daily cannabis users.
    Mørland J; Bramness JG
    Forensic Sci Int; 2020 Apr; 309():110188. PubMed ID: 32120192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood and Oral Fluid Cannabinoid Profiles of Frequent and Occasional Cannabis Smokers.
    Hoffman MA; Hubbard JA; Sobolesky PM; Smith BE; Suhandynata RT; Sanford S; Sones EG; Ellis S; Umlauf A; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
    J Anal Toxicol; 2021 Sep; 45(8):851-862. PubMed ID: 34173005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.
    Lee D; Bergamaschi MM; Milman G; Barnes AJ; Queiroz RH; Vandrey R; Huestis MA
    J Anal Toxicol; 2015 Oct; 39(8):580-7. PubMed ID: 26378131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fitness to drive and cannabis: validation of two blood THCCOOH thresholds to distinguish occasional users from heavy smokers.
    Fabritius M; Augsburger M; Chtioui H; Favrat B; Giroud C
    Forensic Sci Int; 2014 Sep; 242():1-8. PubMed ID: 24999608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users.
    Huestis MA; Blount BC; Milan DF; Newmeyer MN; Schroeder J; Smith ML
    Drug Test Anal; 2019 Jul; 11(7):968-975. PubMed ID: 30756523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol.
    Hartman RL; Brown TL; Milavetz G; Spurgin A; Gorelick DA; Gaffney G; Huestis MA
    Clin Chem; 2015 Jun; 61(6):850-69. PubMed ID: 26019183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
    Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG
    Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers.
    Lemos NP; San Nicolas AC; Volk JA; Ingle EA; Williams CM
    J Anal Toxicol; 2015 Oct; 39(8):588-601. PubMed ID: 26378132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.